Please assess the completion status of the following clinical trial:

Trial Title: Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* aged between 20 and 80 years old~* dark iris~* require binocular indirect ophthalmoscopy for complete ocular examination~* signed written consent forms~Exclusion Criteria:~* history of ocular trauma~* history of intraocular surgery~* history of laser treatment~* previous eye drop instillation that may affect pupillary dilation~* ocular diseases that may affect pupil size such as Horner's syndrome, Adies' pupil, glaucoma and uveitis~* history of diabetes mellitus, severe hypertension and cardiovascular diseases

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: ACTIVE_COMPARATOR): single dose vs three doses of 1%tropicamide and 10%phenylephrine

Based on this trial design, predict the completion outcome and termination type (if applicable).